No writing assistance was utilized in the production of this manuscript. Worldwide, respiratory syncytial virus (RSV) is the most important cause of bronchiolitis and pneumonia in infants.
With Moderna’s COVID-19 sales on the backfoot following the switch to an endemic vaccine market, the Massachusetts-based ...
The respiratory syncytial virus (RSV) is at peak circulation in the country and influenza virus infections are starting to ...
Respiratory syncytial virus infection (RSV) is an illness that affects the lungs and breathing passages. It typically resolves without medication. However, if the condition is severe, medications ...
RSV-related ALRI incidence was significantly higher among preterm infants than term infants. 2. This pattern for RSV ...
A new study from the Texas A&M University School of Public Health found that only 9 percent of older Americans had been vaccinated against respiratory syncytial virus (RSV) prior to this fall and ...
Although substantial variations in RSV seasonality were observed across provinces of China, our study identified distinct transmission zones with shared RSV circulating patterns. These findings could ...
Even with the threat of a potential new competitor in the respiratory syncytial virus (RSV) vaccine race on the horizon, GSK ...
Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizationsNew real-world evidence shows Beyfortus ...
Respiratory syncytial virus (RSV) infections are the leading cause of viral death in infants, although RSV-related mortality has decreased since the development and approval of prophylactic ...
The "SYNAGIS Market Size, Forecast, Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about SYNAGIS for Respiratory syncytial virus ...
Timely diagnosis of RSV is imperative for optimal patient management; by rapidly identifying RSV infection, health professionals can implement appropriate infection control measures while limiting ...